Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Holistic management of patients with ALK-positive NSCLC

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 03.10.19
Views: 2733

Rachel Thomas and Jackie Fenemore

Rachel Thomas (Guy's and St Thomas' Hospital, London, UK) and Jackie Fenemore (The Christie Hospital NHS Foundation Trust, Manchester, UK) discuss the clinical management of patients with ALK-positive non-small-cell lung (NSCLC) cancer patients at ESMO 2019 in Barcelona.

The experts first share their experiences of managing these patients in the clinic - including the diagnostic challenges and side effects that these patients are faced with.

Rachel and Jackie also take a holistic view, by discussing the emotional and psychological support available for these patients.

The experts conclude by outlining the most important things for healthcare professionals to remember when treating these patients.

This programme has been supported by an unrestricted educational grant from Roche.

Management of ALK-positive NSCLC patients in the clinic
Emotional and psychological support for patients
Psychological effects of treatment
Advice for healthcare professionals


Related videos

follow us

Donate to ecancer

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation